1-(4-Chloro-3-nitrobenzenesulfonyl)-4-methylpiperidine

Catalog No.: 
ACJWFK217
CAS No.: 
324058-76-6
Molecular Formula: 
C12H15ClN2O4S
Molecular Weight: 
318.78
1-(4-Chloro-3-nitrobenzenesulfonyl)-4-methylpiperidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$70.00InquiryInquiry
100mg95%$100.00InquiryInquiry
250mg95%$132.00InquiryInquiry
1g95%$336.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Chloro-3-nitrobenzenesulfonyl)-4-methylpiperidine
IUPAC Name1-((4-chloro-3-nitrophenyl)sulfonyl)-4-methylpiperidine
MDL No.MFCD01004791
Molecular FormulaC12H15ClN2O4S
Molecular Weight318.78
SMILESCC1CCN(S(=O)(C2=CC=C(Cl)C([N+]([O-])=O)=C2)=O)CC1
InChI KeyIWCCGUDKOSKNHO-UHFFFAOYSA-N
SynonymPiperidine, 1-[(4-chloro-3-nitrophenyl)sulfonyl]-4-methyl-
CAS No.324058-76-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACJWFK217 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJWFK217 route product structure diagram
    ACJWFK217324058-76-6
Inquiry

2. ACJWFK217 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJWFK217 route product structure diagram
    ACJWFK217324058-76-6
Inquiry

3. ACJWFK217 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJWFK217 route product structure diagram
    ACJWFK217324058-76-6
Inquiry

Comments (0)